Cited by 172Tryptophan and brain disordersHIV Research and TreatmentInfectious Diseases and Tuberculosis

Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients

Huengsberg, Mia, Winer, John B, Gompels, Mark, Round, Rachel, Ross, Jonathan, Shahmanesh, Mohsen·1998·Clinical Chemistry

Abstract

An alternative pathway of Trp metabolism involves the conversion of Trp to kynurenine by indoleamine-2,3-dioxygenase, which leads to synthesis of the neurotoxin, quinolinic acid. This study explores the relationship of indoleamine-2,3-dioxygenase activity with stages of HIV infection. Sera from 206 HIV-positive and 72 seronegative subjects were analyzed for Trp and kynurenine. The kynurenine-to-Trp (KT) ratio was calculated. The mean KT ratio of seronegative controls was 36.6 ± 10.9, and the median ratio was 34.9. The upper limit of the seronegative KT ratio, defined as mean + 2 SD, was 58.4. Patients with HIV infection showed a reciprocal relationship between the KT ratio, the CD4 count, and the stage of the disease. The median KT ratios for asymptomatic and AIDS patients were 50.5 and 117.0, respectively. This study shows that the serum Trp concentration is markedly decreased and that the kynurenine concentration is increased with immune stimulation in HIV infection. This may lead to changes in quinolinic acid and explain some of the pathogenesis of AIDS dementia.

Integrity signals

Registry

Crossref · 10.1093/clinchem/44.4.858

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Authors
Huengsberg, M., Winer, J. B., Gompels, M., Round, R., Ross, J., & Shahmanesh, M.
Affiliations
  • Department of GU Medicine, Whittall Street Clinic, Birmingham B4-6 DH, UK
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • Royal Victoria Infirmary (GB)
Corresponding author
Huengsberg, Mia
Venue
Clinical Chemistry
Published
1998-04-01
Volume
44
Issue
4
Pages
858-862
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W2131301672
Cited by
172
References
0
Citations by year
2026: 1 · 2025: 7 · 2024: 21 · 2023: 3 · 2022: 4 · 2021: 12 · 2020: 10 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 13 · 2015: 14 · 2014: 7 · 2013: 8 · 2012: 2
FWCI
0.86
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
Keywords
kynurenine/tryptophan ratio, tryptophan metabolism, indoleamine 2,3-dioxygenase, quinolinic acid, HIV infection, AIDS, CD4 count, disease progression, serum tryptophan, neurotoxicity, HIV-associated dementia
MeSH terms
Acquired Immunodeficiency Syndrome, Adult, Aged, Female, Humans, Kynurenine, Male, Middle Aged, Peripheral Nervous System Diseases, Prospective Studies, Retrospective Studies, Tryptophan, Tryptophan Oxygenase, AIDS Dementia Complex, HIV Seronegativity, CD4 Lymphocyte Count

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review